Strothotte, S; Strigl-Pill, N; Grunert, B et al.
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trialJOURNAL OF NEUROLOGY. Bd. 257. H. 1. 2010 S. 91-97
Knuf, M
ESBLKLINISCHE PADIATRIE. Bd. 222. 2010 S. S9-S9
Beck, M; Muenzer, J; Scarpa, M
Evaluation of disease severity in mucopolysaccharidosesJournal of Pediatric Rehabilitation Medicine. Bd. 3. 2010 S. 39-46
Zillessen, U; Li, H; Mildenberger, E
Expression of NO synthases and redox enzymes in umbilical arteries from newborns born small, appropriate, and large for gestational age [Abstract]Pediatr Res. Bd. 68. H. Spl1. 2010 S. 110-111
Mehta, A; Beck, M; Eyskens, F et al.
Fabry disease: a review of current management strategiesQJM-AN INTERNATIONAL JOURNAL OF MEDICINE. Bd. 103. H. 9. 2010 S. 641-659
Merz, C; Mengel, E; Hartung, R et al.
Fabry disease: change-over of preparations may avoid infusion-related adverse events and secure continuation of enzyme replacement therapyINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. Bd. 48. 2010 S. S63-S64
Mildenberger, E
Familienzentrierte Neonatologie: Rooming-in für kranke NeugeboreneFRÜHE KINDHEIT. Bd. 13. 2010 S. 6-9
Brixel, LR; Ingenbrandt, CS; Fleig, A et al.
Fine-tuning of insulin secretion (Poster GfH Tagung 2010)MEDIZINISCHE GENETIK. Bd. 1. 2010 S. 1ff
Hollak, CEM; vom Dahl, S; Aerts, JMFG et al.
Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher diseaseBLOOD CELLS MOLECULES AND DISEASES. Bd. 44. H. 1. 2010 S. 41-47
Schiffmann, R; Martin, RA; Reimschisel, T et al.
Four-Year Prospective Clinical Trial of Agalsidase Alfa in Children with Fabry DiseaseJOURNAL OF PEDIATRICS. Bd. 156. H. 5. 2010 S. 832-U196